Beam Therapeutics Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $245.6M | $162.2M |
| FY2021 | — | $826.7M | $560.0M |
| FY2022 | — | $733.5M | $232.8M |
| FY2023 | — | $981.3M | $435.9M |
| FY2024 | — | $733.5M | $282.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $245.6M | $162.2M |
| FY2021 | — | $826.7M | $560.0M |
| FY2022 | — | $733.5M | $232.8M |
| FY2023 | — | $981.3M | $435.9M |
| FY2024 | — | $733.5M | $282.0M |